Effect of oral stabilized oxygen on patients with fallot's tetralogy

ABSTRACT

Fallot's tetralogy is a common congenital cyanotic heart disease affecting 0.2-0.3 per 1000 live births.[1] This study was done to evaluate the effect of oral stabilized oxygen therapy on patients with Fallots tetralogy. The present work included 15 children [10 boys and 5 girls] with an age range from one month to 8 years diagnosed as Fallot's tetralogy. The patients received oral stabilized oxygen for one month, Blood gases were done before, one, two and four weeks while the patient on oral oxygen therapy and two weeks after stoppage of oral oxygen. Echocardiography, complete blood count and hematocrit values were done before starting and after one month while the patient was on oral oxygen therapy. It was found that there was marked rise In SaO[2], and PaO[2] while the patients were on oral oxygen therapy than before initiation and after stoppage of oral oxygen therapy but without any echocardiographic changes, indicating that these changes in blood oxygenation are merely due to gastrointestinal absorption of oxygen. There was highly significant reduction in the level of hemoglobin, red cell count, and Hematocrit after than before oral oxygen therapy